Floatz logo

Therapeutic Asset Ratings

271 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
INTERFERON ALFA-2B
HLA-A2 Positive Cells Present
Roswell Park Cancer InstituteP2CCC (53)
Lamivudine
Small Cell Lung Carcinoma
Roswell Park Cancer InstituteP2CCC (53)
Montanide Isa 51
Gliosarcoma
Roswell Park Cancer InstituteP2CCC (53)
Pegcetacoplan
Fallopian Tube Carcinosarcoma
Roswell Park Cancer InstituteP2CCC (53)
Pegcetacoplan
Fallopian Tube Clear Cell Adenocarcinoma
Roswell Park Cancer InstituteP2CCC (53)
Pegcetacoplan
Fallopian Tube Endometrioid Adenocarcinoma
Roswell Park Cancer InstituteP2CCC (53)
Pegcetacoplan
Fallopian Tube Serous Adenocarcinoma
Roswell Park Cancer InstituteP2CCC (53)
Pegcetacoplan
Ovarian Carcinosarcoma
Roswell Park Cancer InstituteP2CCC (53)
Pegcetacoplan
Ovarian Clear Cell Adenocarcinoma
Roswell Park Cancer InstituteP2CCC (53)
Pegcetacoplan
Ovarian Endometrioid Adenocarcinoma
Roswell Park Cancer InstituteP2CCC (53)
Pegcetacoplan
Ovarian Serous Adenocarcinoma
Roswell Park Cancer InstituteP2CCC (53)
Pegcetacoplan
Primary Peritoneal Carcinosarcoma
Roswell Park Cancer InstituteP2CCC (53)
Pegcetacoplan
Primary Peritoneal Carcinoma
Roswell Park Cancer InstituteP2CCC (53)
Pegcetacoplan
Primary Peritoneal Endometrioid Adenocarcinoma
Roswell Park Cancer InstituteP2CCC (53)
Pegcetacoplan
Primary Peritoneal Serous Adenocarcinoma
Roswell Park Cancer InstituteP2CCC (53)
Pegcetacoplan
Fallopian Tube Carcinoma
Roswell Park Cancer InstituteP2CCC (53)
Pegcetacoplan
Ovarian Carcinoma
Roswell Park Cancer InstituteP2CCC (53)
Pembrolizumab
Mismatch Repair Proficient
Roswell Park Cancer InstituteP2CCC (53)
Pembrolizumab
Primary Peritoneal Endometrioid Adenocarcinoma
Roswell Park Cancer InstituteP2CCC (53)
Pembrolizumab
Endometrial Serous Adenocarcinoma
Roswell Park Cancer InstituteP2CCC (53)
Sargramostim
Digestive System Neuroendocrine Neoplasm
Roswell Park Cancer InstituteP2CCC (53)
Sargramostim
Lung Neuroendocrine Neoplasm
Roswell Park Cancer InstituteP2CCC (53)
Sargramostim
Cancer
Roswell Park Cancer InstituteP2CCC (53)
Sargramostim
Pancreatic Neuroendocrine Neoplasm
Roswell Park Cancer InstituteP2CCC (53)
Survaxm
Digestive System Neuroendocrine Neoplasm
Roswell Park Cancer InstituteP2CCC (53)
Showing 126 to 150 of 271 assets
PreviousPage 6 of 11Next